HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal Metastasis
Clinical trial NCT04889768 · UNKNOWN
Trial details
- NCT number
- NCT04889768
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-31
- Primary completion
- 2023-07-31
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.